The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants jeopardizes the protective antiviral immunity induced after infection or …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for
coronavirus disease 2019 (COVID-19), continues to cause substantial morbidity and mortality …

With the constant threat of emergence of a novel influenza virus pandemic, there must be
continued evaluation of the molecular mechanisms that contribute to virulence. Although the …

Influenza A viruses (IAVs) constitute a major threat to human health. The IAV genome consists
of eight single-stranded viral RNA segments contained in separate viral ribonucleoprotein …

Highly pathogenic avian influenza A(H5N1) viruses of clade 2.3.4.4b underwent an explosive
geographic expansion in 2021 among wild birds and domestic poultry across Asia, Europe…

Evidence suggests that innate and adaptive cellular responses mediate resistance to the
influenza virus and confer protection after vaccination. However, few studies have resolved the …

Vaccination, especially with multiple doses, provides substantial population-level protection
against COVID-19, but emerging variants of concern (VOC) and waning immunity represent …

The zoonotic origin of the COVID-19 pandemic virus highlights the need to fill the vast gaps
in our knowledge of SARS-CoV-2 ecology and evolution in non-human hosts. Here, we …

Variants of concern (VOC) of SARS-CoV2 and waning immunity pose a serious global
problem. Overall, vaccination and prior infection appear to provide significant protection to the …

A segmented genome enables influenza virus to undergo reassortment when two viruses
infect the same cell. Although reassortment is involved in the creation of pandemic influenza …